HAUMANN BRETT K 4
4 · Theravance Biopharma, Inc. · Filed Nov 24, 2020
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2020-11-20$17.21/sh−4,639$79,837→ 278,171 total
4 · Theravance Biopharma, Inc. · Filed Nov 24, 2020
Ordinary Shares